Over $2M Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders have recently made notable purchases in Donegal Group Inc. (DGICA), Nuvectis Pharma, Inc. (NVCT), and Oil-Dri Corporation of America (ODC). Donegal posted downbeat quarterly earnings, Nuvectis Pharma announced FDA clearance of NXP900 IND, and Oil-Dri Corp of America reported an increase in third-quarter sales.
June 20, 2023 | 11:01 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nuvectis Pharma's 10% owner, Charles Mosseri-Marlio, acquired 32,124 shares at an average price of $17.71, costing around $568.85 thousand, following the FDA clearance of NXP900 IND.
The insider purchase in Nuvectis Pharma indicates confidence in the company's prospects following the FDA clearance of NXP900 IND. This positive news may lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Oil-Dri Corporation of America's Director, Allan Selig, bought 1,000 shares at an average price of $50.55, costing around $50.55 thousand, following an increase in third-quarter sales.
The insider purchase in Oil-Dri Corporation of America indicates confidence in the company's prospects following an increase in third-quarter sales. This positive news may lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEUTRAL IMPACT
Donegal Group Inc.'s 10% owner acquired 146,427 shares at an average price of $15.57, costing around $2.28 million, following downbeat quarterly earnings.
The insider purchase indicates confidence in the company's prospects despite downbeat earnings. However, insider purchases should not be the sole indicator for investment decisions, and the short-term impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100